Depression
Medications
Related eMedTV
Health Channels

Cymbalta Dosage

A person's Cymbalta dosage is often determined by the medical condition being treated and existing medical conditions, among other things. The recommended starting dose for treating neuropathic pain or generalized anxiety disorder is 60 mg once daily. The recommended starting dose of Cymbalta for treating depression is 20 mg twice daily, 30 mg twice daily, or 60 mg once daily. For fibromyalgia, the recommended starting dosage is 30 mg once a day.

 

Dosage of Cymbalta: An Introduction

The dose of
 Cymbalta® (duloxetine hydrochloride) your healthcare provider prescribes will vary, depending on a number of factors, including:
 
  • The medical condition you are being treated for
  • Other medical conditions you may have
  • Other medications you may be taking.
     
As is always the case, do not adjust your dose unless your healthcare provider specifically instructs you to do so.
 
Cymbalta Dose for Depression
The recommended dose for depression is Cymbalta 20 mg twice daily, 30 mg twice daily, or 60 mg once daily. Doses above 60 mg per day are not recommended.
 
Cymbalta Dosage for Neuropathic Pain
The recommended dosage of Cymbalta for peripheral diabetic neuropathy pain is 60 mg once daily. Your healthcare provider may decide to start you at a lower dose, especially if you have kidney problems.
 
Cymbalta Dose for Anxiety
The recommended dose for generalized anxiety disorder is 60 mg once daily. Your healthcare provider may decide to start you at a lower dose (Cymbalta 30 mg once daily) for a week before increasing your Cymbalta dosage to 60 mg once daily, although this is not necessary for everyone.
 
Cymbalta Dose for Fibromyalgia
The recommended starting dose for fibromyalgia treatment is Cymbalta 30 mg once a day for one week, after which your healthcare provider may increase the dose to Cymbalta 60 mg once daily.
 
(Cymbalta Dosage Continued: Page 2)
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;